ELIGIBILITY

Applicants must meet the following requirements:

Hold an MD or PhD (equivalent degree) at time of award
Early to Mid-career scientists with a strong research track record who hold a position at a recognized research institution in one of the eligible countries at the time of application (see below for list of countries) and whose tenure of that position
encompasses the projected period of the award from the Gilead and Kite scholarship program
This program is designed for non-faculty members who are within 3-5 years of obtaining a faculty appointment. MD or PhD qualifications would have to have been obtained within the last 8 years. Exceptions can apply
Have a strong career interest in hematology/oncology
Have a research mentor with extensive experience in the field of hematology/oncology
Be able to devote approximately 50% of their professional time to research for the next two years
Be able to complete the proposed research within the two-year award period

Citizenship

The Research Scholars Program in Hematologic Malignancies is open to emerging investigators from countries with the following regions’

Europe, Asia, Australia and South America
An applicant must be a citizen or permanent resident of one of the eligible countries or subject to the requirements noted below with regards to temporary visa/work permit. This visa must be valid for the duration of the award period or the applicant must be able to demonstrate that they are eligible for an extension, renewal or other status that will enable the applicant to undertake the research for the entirety of the two-year award.

registered trademarks of Gilead Sciences, Inc., or one of its related companies. Kite
and the Kite Logo are registered trademarks of Kite, a Gilead company.